Well Cephalon paid a 45% premium for a 19.99% equity stake a decade ago .... whether we get one now remains to be seen .... I guess it will depend how badly this "targeted industry investor" wants in ?
MESOBLAST AND CEPHALON ENTER INTO STRATEGIC ALLIANCE TO COMMERCIALIZE NOVEL THERAPEUTIC PRODUCTS FOR REGENERATIVE MEDICINE
Cephalon to receive exclusive worldwide commercialization rights to selected Mesoblast products
Alliance to focus on degenerative conditions of neurologic and cardiovascular systems
Mesoblast to receive upfront fee of US$130 million and up to US$1.7 billion in milestone payments
Cephalon to acquire stake in Mesoblast at a 45% premium
Mesoblast cash balance of $250 million to fund other major indications including diabetes, autoimmune and inflammatory diseases, ophthalmic indications and key orthopedic bone and cartilage conditions
Ann: Trading Halt, page-114
-
- There are more pages in this discussion • 159 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
96.0¢ |
Change
0.025(2.67%) |
Mkt cap ! $1.096B | |||
| Open | High | Low | Value | Volume |
| 95.0¢ | 96.5¢ | 94.0¢ | $1.231M | 1.291M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 94461 | 95.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 96.0¢ | 61151 | 6 |
View Market Depth
| Last trade - 16.10pm 12/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |